CRISPR-Based Diagnostics Market Revenue to Attain USD 12.98 Bn by 2033

Published: 17 Nov 2025

Author: Precedence Research

Share :

Table of Content

1. CRISPR-Based Diagnostics Market Revenue and Trends 2025 to 2033 2. Key drivers enabling the growth of this market 3. Segment Insights 4. Regional Insights 5. CRISPR-Based Diagnostics Market Coverage

CRISPR-Based Diagnostics Market Revenue and Trends 2025 to 2033

The global CRISPR-based diagnostics market revenue reached USD 3.79 billion in 2025 and is predicted to attain around USD 12.98 billion by 2033 with a CAGR of 16.63%. This market is rising because CRISPR diagnostic tools offer unparalleled sensitivity, speed, multiplexing ability, and adaptability to minimal laboratory infrastructure; they are increasingly preferred over conventional molecular assays in clinical, field, and home settings.

Key drivers enabling the growth of this market

The rising frequency and urgency of infectious diseases (pandemics, antimicrobial resistance, and emerging pathogens) are primary growth factors driving demand increases for rapid diagnostics. Expanded public funding for genomic surveillance has enabled CRISPR and CRISPR-derived tools to become a leading player. Technological innovations in guide RNA design, collateral cleavage detection, and enzyme engineering will further improve performance by increasing sensitivity, reducing costs, and lowering false-positive rates. A shift toward decentralization (point-of-care testing) is driving the average assay to be portable and to omit a sample preparation step for research purposes, while still being performed outside a central laboratory. Biotech companies working with diagnostics labs lead to advancing commercialization and regulatory review timelines. Ongoing expansions in oncology, genetics, and personalized medicine continue to expand the available market.

Segment Insights

• By Product Type, the kits and assays segment dominated the CRISPR-based diagnostics market in 2024 due to the convenience, standardized performance, and rapid outcomes.
• By Technology / CRISPR Platform, the Cas12-based diagnostic segment is the dominant segment, owing to its improved sensitivity, collateral cleavage mechanism, and compatibility with isothermal amplification.
• By Detection Method / Readout, the fluorescence-based detection segment dominates the market because of its high precision, rapid visualization of signal antigen detection, and multiplexing ability. It also provides reliable quantitative outputs.
• By Application, the infectious disease detection segment dominates the market, increasing global demand for rapid and accurate diagnostic devices for diagnosing viruses and bacteria, including COVID-19, influenza, tuberculosis, and antimicrobial-resistant pathogens in a timely manner.
• By Distribution Channel, the direct sales to hospitals and healthcare setting segment dominates the market due to increasing partnerships between biotechnology companies and healthcare providers.

Regional Insights

North America continues to lead the market and captures a sizable share, driven by strong research, funding, leading biotech ecosystems, a favorable regulatory environment, and early clinical use of CRISPR diagnostics. The United States, in particular, is a center for piloting and commercial releases.

On the other hand, the Asia-Pacific region is expected to be the fastest-growing. Emerging markets in China, India, South Korea, and Southeast Asia are rapidly adopting molecular diagnostics; local markets offer significant manufacturing investment opportunities and a lower cost structure, positioning APAC as a growth region.

CRISPR-Based Diagnostics Market Coverage

Recent Development

• In May 2024, Sherlock Bio launched a trial for an over-the-counter CRISPR test for STIs (chlamydia, gonorrhea), aiming for a mid-2025 commercial launch.
  (Source- https://www.reuters.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7104

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344